Pursuant to Regulation 32 of SEBI (LODR) Regulations, 2015, we here by Confirm that there is no deviation or variation in the Utilization of proceeds of the IPO from the objects stated ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amwill Health Care has filed a SEBI compliance statement confirming that its IPO proceeds of ₹48.88 crore, raised on 12 February 2025, are being used exactly as outlined in the prospectus, with no deviation. As of 31 March 2025, the company has utilized about ₹667 lakhs — ₹288.36 lakhs for working capital, ₹61.51 lakhs for marketing and brand building, ₹316.76 lakhs for general corporate purposes, and fully paid the ₹669.66 lakhs in issue expenses. The remaining unutilized ₹3,500 lakhs is parked in bank term deposits, and ₹51.72 lakhs sits in current bank accounts pending deployment. The audit committee reviewed and approved the statement at its meeting held on 29 May 2025.
This is a routine, neutral-to-positive compliance filing — it reassures shareholders that IPO money is not being misused, but the low utilization rate in the first quarter means investors should watch upcoming quarters to confirm the remaining ₹3,500 lakhs gets deployed on schedule into working capital, marketing, and general corporate purposes.